0001209191-20-016213.txt : 20200304
0001209191-20-016213.hdr.sgml : 20200304
20200304170407
ACCESSION NUMBER: 0001209191-20-016213
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200302
FILED AS OF DATE: 20200304
DATE AS OF CHANGE: 20200304
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Chhabra Meenu
CENTRAL INDEX KEY: 0001534200
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37695
FILM NUMBER: 20688138
MAIL ADDRESS:
STREET 1: 1600 FAIRVIEW AVE. E.
STREET 2: SUITE 300
CITY: SEATTLE
STATE: WA
ZIP: 98102
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PROTEOSTASIS THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001445283
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
BUSINESS ADDRESS:
STREET 1: 80 GUEST STREET
STREET 2: 5TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02135
BUSINESS PHONE: 617-225-0096
MAIL ADDRESS:
STREET 1: 80 GUEST STREET
STREET 2: 5TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02135
FORMER COMPANY:
FORMER CONFORMED NAME: PROTEOSTASIS THERAPEUTICS INC
DATE OF NAME CHANGE: 20080916
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-03-02
0
0001445283
PROTEOSTASIS THERAPEUTICS, INC.
PTI
0001534200
Chhabra Meenu
C/O PROTEOSTASIS THERAPEUTICS, INC.
80 GUEST STREET, SUITE 500
BOSTON
MA
02135
1
1
0
0
President and CEO
Employee Stock Option (right to buy)
1.57
2020-03-02
4
A
0
406800
0.00
A
2030-03-02
Common Stock
406800
406800
D
These securities shall vest and become exercisable in a series of installments, with the first installment to become exercisable for 25% of the underlying common stock on February 4, 2021, and thereafter vesting and becoming exercisable in 12 quarterly installments as nearly equal as practicable (as determined by the Issuer in its reasonable discretion), until such stock option becomes fully exercisable on February 4, 2024, provided that the Reporting Person remains an employee of Issuer at all times during the applicable vesting period of such securities.
/s/ Janet Smart, Attorney-in-Fact
2020-03-04